◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Vicarious Surgical Inc.

CIK: 1812173 SIC: 3842
-
Revenue
$-50.18M
Net Income
-
Gross Margin
-
Op. Margin
$-82.14M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 16 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Operating Expenses $9.26M $11.50M $13.52M $15.75M $14.98M $17.75M $17.71M
Research & Development $7.14M $7.99M $9.05M $9.41M $8.46M $10.80M $10.92M
Operating Income $-9.26M $-11.50M $-13.52M $-15.75M $-14.98M $-17.75M $-17.71M
Interest Income - - - - - $802.00K -
Income Before Tax $-10.52M $-11.06M $-13.21M $-15.39M $-13.93M $-17.09M $-15.21M
Net Income $-10.52M $-11.06M $-13.21M $-15.39M $-13.93M $-17.09M $-15.21M
Basic EPS nan nan nan nan nan nan -2.59
Diluted EPS nan nan nan nan nan nan -2.59
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $2.57M $3.16M $3.91M $2.60M $9.74M $7.07M $20.25M
Short-term Investments $7.22M $10.25M $20.05M $34.76M $39.36M $53.80M $52.98M
Other Current Assets $1.79M $1.66M $2.10M $2.29M $2.60M $3.11M $2.70M
Total Current Assets $11.58M $15.07M $26.07M $39.65M $51.70M $63.98M $75.93M
Property Plant & Equipment $1.27M $3.48M $3.79M $4.11M $4.48M $4.82M $5.33M
Other Non-current Assets $29.00K $39.00K $21.00K $31.00K $49.00K $89.00K $132.00K
Total Assets $19.58M $29.35M $40.89M $55.05M $67.72M $80.62M $93.35M
Accounts Payable $894.00K $915.00K $721.00K $1.02M $1.17M $2.42M $1.35M
Accrued Liabilities $1.06M $905.00K $3.07M $5.57M $5.28M $5.01M $4.70M
Total Current Liabilities $3.90M $3.18M $5.10M $7.86M $7.67M $8.60M $7.18M
Total Liabilities $9.74M $15.26M $17.83M $20.98M $21.02M $22.73M $21.49M
Retained Earnings $-246.12M $-235.60M $-224.54M $-211.33M $-195.94M $-182.01M $-164.92M
Total Stockholders Equity $9.84M $14.09M $23.06M $34.08M $46.70M $57.88M $71.86M
Total Liabilities & Equity $19.58M $29.35M $40.89M $55.05M $67.72M $80.62M $93.35M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-10.52M $-11.06M $-28.61M $-15.39M $-13.93M $-17.09M $-15.21M
Stock-based Compensation $1.10M $7.03M $4.98M $2.79M $2.81M $9.09M $6.16M
Change in Payables $-10.00K $-262.00K $-537.00K $-145.00K $-233.00K $137.00K $97.00K
Operating Cash Flow $-9.31M $-35.76M $-25.30M $-11.77M $-11.79M $-38.17M $-25.48M
Capital Expenditure - - $5.00K $5.00K - - $16.00K
Purchases of Investments - - - - - $52.78M $38.89M
Investing Cash Flow $3.02M $29.12M $19.43M $4.61M $14.45M $-7.59M $-7.09M
Financing Cash Flow $5.69M $67.00K $41.00K $17.00K $6.00K $2.00K $2.00K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $11.50M $17.75M $40.77M $51.58M
Research & Development $7.99M $10.80M $26.46M $31.69M
Operating Income $-11.50M $-17.75M $-40.77M $-51.58M
Income Before Tax $-11.06M $-17.09M $-39.67M $-49.30M
Income Tax Expense - - - -
Net Income $-11.06M $-17.09M $-39.67M $-49.30M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.16M $9.74M
Short-term Investments $10.25M $39.36M
Other Current Assets $1.66M $2.60M
Total Current Assets $15.07M $51.70M
Property Plant & Equipment $3.48M $4.48M
Other Non-current Assets $39.00K $49.00K
Total Assets $29.35M $67.72M
Accounts Payable $915.00K $1.17M
Accrued Liabilities $905.00K $5.28M
Total Current Liabilities $3.18M $7.67M
Total Liabilities $15.26M $21.02M
Retained Earnings $-235.60M $-195.94M
Total Stockholders Equity $14.09M $46.70M
Total Liabilities & Equity $29.35M $67.72M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-11.06M $-17.09M $-39.67M $-49.30M
Stock-based Compensation - - $7.03M $9.09M
Change in Payables - - $-262.00K $137.00K
Operating Cash Flow - - $-35.76M $-38.17M
Investing Cash Flow - - $29.12M $-7.59M
Financing Cash Flow - - $67.00K $2.00K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...